EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Sustainable Innovation in Biopharma: Aligning Therapeutic Progress with Environmental Responsibility
To genuinely align RD with environmental responsibility biopharma organisations must embrace systemic structural and cultural transformations
Advisory Board
KNOWLEDGE BANK
-
Articles
Pharma Display Advertising: Boost Leads & Webinar Registrations Instantly
With the ever growing competition in the pharmaceutical industry firms are always trying to find viable methods of accessing decisionmakers creating qualified leads and marketing thought leadership opportunities eg webinars The old ways of outreach are no longer effective in the digitalfirst environment where the executives of healthcare the researchers of pharmaceuticals and the leaders of the in...
-
Techno Trends
Case Western Reserve Scientists Discover Novel Molecular Target for Parkinson’s Disease
Researchers at Case Western Reserve University have discovered a new biochemical pathway that could lead to treatments targeting the underlying causes of Parkinsons disease
-
Projects
PharmaEssentia Invests $46M to Expand U.S. Manufacturing Footprint for BESREMi®
PharmaEssentia Corporation has announced plans to establish a new wholly owned manufacturing subsidiary in Puerto Rico The US million investment aims to expand the production of BESREMi
-
Research Insights
Controllable protein design via autoregressive direct coupling analysis conditioned on principal components
We present FeatureDCA a statistical framework for protein sequence modeling and generation that extends Direct Coupling Analysis DCA
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
Building a Sustainable Supply Chain for 2030
Niklas Adamsson
-
2
Solutions from Technology to Innovation: Transforming Pharmaceutical Production in North America
Kate Williamson
The integration of technology is reshaping pharmaceutical production in North America, with automation, data analytics, 3D printing, regulatory compliance tools, blockchain, and remote monitoring play...
-
3
How Proteomics Is Revolutionizing R&D across Biopharma and Life Sciences
Kate Williamson
Through proteomics, the biopharmaceutical research and development process gets revolutionized since it brings improved insights about disease mechanisms and speeds up drug finding methods while boost...
-
4
Efficiency and Quality in Pharma: Leveraging Lean Six Sigma Integration
Kate Williamson
This article explores the integration of Lean Six Sigma principles in the pharmaceutical industry to enhance efficiency and quality. It covers benefits such as improved process efficiency, enhanced pr...
-
5
Challenges and Opportunities in Market Access for New Drugs
Kate Williamson
Navigating market access for new drugs involves overcoming regulatory hurdles, high development costs, clinical trial challenges, and pricing issues. Opportunities include innovative regulatory pathwa...
press releasesRead more...
The 0.05 EU/mg Breakthrough: How Sino Biological ProPure™ Is Redefining the Ultra-Low Endotoxin Standard
When we discuss bacterial infections we often think of exotoxinsthose soluble proteins actively secreted by bacteriawhile overlooking endotoxins which are more insidious but equally dangerous Endotoxins are not released by bacteria rather they are natural components residing in the bacterial
Ramarketing acquires US market research firm ISR
Strategic life sciences marketing agency ramarketing has completed the acquisition of ISR Market Research a specialist agency based in North Carolinas Research Triangle Park RTP one of the largest pharmaceutical and biopharma hubs in North America
Affinia Therapeutics Granted FDA Fast Track Designation for AFTX-201 as a Treatment for People Living with BAG3-Associated Dilated Cardiomyopathy (DCM)
Affinia Therapeutics Affinia an innovative gene therapy company with a pipeline of firstinclass andor bestinclass adenoassociated virus AAV gene therapies initially for devastating cardiovascular diseases
Vasomune Therapeutics, Inc., and AnGes, Inc., Announce US FDA Clearance of Investigational New Drug (IND) Application For Pegevongitide (AV-001) Treatment in Resuscitation of Severely Burned Patients
Vasomune Therapeutics Inc a clinicalstage biopharmaceutical company today announced US Food and Drug Administration FDA clearance of the Investigational New Drug IND application to develop Pegevongitide AV
Events Read more...
09 - 11
Mar 20268th International Conference
8105, Suite 112, Rasor Blvd, Plano TX 75024, USA
10 - 12
Mar 2026Bioprocessing Summit Europe 2026
InterContinental Barcelona, Spain
10 - 10
Mar 2026Age of AI Europe 2026
Institute of Engineering and Technology (IET) London,UK
10 - 12
Mar 2026Healthcare & Hospi.Log Asia 2026
Singapore
11 - 12
Mar 20269th Annual Pharma Regulatory Summit 2026
Mumbai, India
16 - 17
Mar 2026Pharma USA 2026
Philadelphia, PA , USA
16 - 18
Mar 2026Pharmaceutics and Novel Drug
Kuala Lumpur, Malaysia
16 - 18
Mar 2026Advanced Clinical Research
Kuala Lumpur, Malaysia
LATEST NEWSRead more...
CSL to expand plasma therapy manufacturing plant in Illinois
CSL Limited has begun expansion work at its plasma therapy manufacturing plant in Kankakee Illinois as part of the companys global manufacturing growth strategy and efforts to strengthen production in the United States
FDA Eases Biosimilar Development Requirements
The US FDA is reducing study requirements for biosimilars to enhance market competition and cut development costs by an estimated million per drug
FDA Greenlights Boehringer's HERNEXEOS as First Targeted Therapy for HER2-Mutant NSCLC
The US FDA has approved Boehringer Ingelheims HERNEXEOS zongertinib tablets as the first targeted initial therapy for adults with advanced nonsmall cell lung cancer harboring HER ERBB tyrosine kinase domain activating mutations
INOVIO and Akeso Collaborate to Study New Combination Therapy for Glioblastoma
INOVIO and Akeso Inc have entered into a clinical trial collaboration and supply agreement to evaluate a new combination therapy for the treatment of Glioblastoma GBM an aggressive form of brain cancer
Sinopia Biosciences to Collaborate with Ono Pharmaceutical on Target Discovery for Rare Metabolic Disorders
Sinopia Biosciences Inc has announced a target discovery collaboration with Ono Pharmaceutical Co Ltd focused on a group of rare metabolic disorders The disorders remain undisclosed and are associated with significant unmet medical need
Vanda Receives FDA Grant for Formal Hearing on HETLIOZ® Application
Vanda Pharmaceuticals Inc has announced that the US Food and Drug Administration FDA has granted its request for a formal evidentiary public hearing regarding the proposed refusal to approve its supplemental

